Literature DB >> 6746891

Proposed revision of the Wauters et al. antigenic scheme for serotyping of Yersinia enterocolitica.

S Aleksić, J Bockemühl.   

Abstract

The antigenic scheme of Wauters and co-workers was applied to serotype a total of 585 strains of Yersinia enterocolitica, 43 strains of Yersinia kristensenii, 40 strains of Yersinia frederiksenii, and 25 strains of Yersinia intermedia. The O antigens 11,23; 11,24; 12,25; 12,26; and 28 were exclusively associated with Y. kristensenii. O antigen 16 was associated with Y. kristensenii and Y. frederiksenii. The serogroups O:4,33 and O:17 were only found in Y. intermedia, whereas the remaining serogroups were associated with Y. enterocolitica. The O antigen 34 proved to be identical with O:10; O factor 29 was poorly expressed and is suggested to be excluded from the list of recognized antigens. As sera of O factors 1, 2a, and 2b of Y. enterocolitica are difficult to prepare, we propose to combine the serogroups O:1,2a,3 and O:2a,2b,3 with O group 3. The H antigens l, r, s, and t were characteristic of Y. kristensenii, whereas H:p was exclusively found in Y. frederiksenii. H:q belonged to Y. intermedia, whereas H:o occurred in Y. kristensenii, Y. frederiksenii, and Y. intermedia. The remaining H factors a to k, m, and n occurred in Y. enterocolitica in various combinations. Up to 15 different combinations of H antigen factors were identified in a single serogroup of Y. enterocolitica. We propose the definition of a new H antigen, u. We suggest the exclusion from the typing scheme of those O and H antigens which are not associated with Y. enterocolitica. For O typing, we present a revised antigenic scheme of Y. enterocolitica with 18 serogroups containing 20 O factors. We emphasize the necessity of its continuous usage, taking into account the international situation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6746891      PMCID: PMC271255          DOI: 10.1128/jcm.20.1.99-102.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  7 in total

1.  [INVESTIGATIONS ON THE CULTURAL--BIOCHEMICAL, SEROLOGIC, EXPERIMENTAL ANIMAL AND IMMUNOLOGIC PROPERTIES OF A TYPE OF BACTERIA CALLED TEMPORARILY "PASTEURELLA X"].

Authors:  W KNAPP; E THAL
Journal:  Zentralbl Bakteriol Orig       Date:  1963-12

2.  Examination of the envelope antigen K1 in Yersinia enterocolitica which was identified as fimbriae.

Authors:  S Aleksić; R Rohde; G Müller; B Wohlers
Journal:  Zentralbl Bakteriol Orig A       Date:  1976-05

3.  [Supplement to the antigenic schema of Yersinia enterocolitica].

Authors:  G Wauters; L Le Minor; A M Chalon; J Lassen
Journal:  Ann Inst Pasteur (Paris)       Date:  1972-05

4.  [Somatic and flagellar antigens of Yersinia enterocolitica].

Authors:  G Wauters; L Le Minor; A M Chalon
Journal:  Ann Inst Pasteur (Paris)       Date:  1971-05

5.  Biotypic and serotypic profiles of 367 Yersinia enterocolitica cultures of human and environmental origin in the United States.

Authors:  T J Quan
Journal:  Contrib Microbiol Immunol       Date:  1979

6.  Summary of the data received at the WHO Reference Center for Yersinia enterocolitica.

Authors:  H H Mollaret; H Bercovier; J M Alonso
Journal:  Contrib Microbiol Immunol       Date:  1979

7.  Speciation in Yersinia.

Authors:  D J Brenner
Journal:  Contrib Microbiol Immunol       Date:  1979
  7 in total
  3 in total

1.  First isolation of virulent Yersinia enterocolitica O8, biotype 1B in Germany.

Authors:  S Schubert; J Bockemühl; U Brendler; J Heesemann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-01-24       Impact factor: 3.267

2.  Development of rRNA-targeted PCR and in situ hybridization with fluorescently labelled oligonucleotides for detection of Yersinia species.

Authors:  K Trebesius; D Harmsen; A Rakin; J Schmelz; J Heesemann
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

3.  Unique activity spectrum of colicin FY: all 110 characterized Yersinia enterocolitica isolates were colicin FY susceptible.

Authors:  Juraj Bosák; Lenka Micenková; Martin Vrba; Alena Ševčíková; Daniela Dědičová; Debora Garzetti; David Šmajs
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.